Effects of weight loss and weight regain on androgen levels and insulin resistance in PCOS.
Official title: The Effect and Mechanism Of Weight Cycling on Hyperandrogenemia And Insulin Resistance in Polycystic Ovary Syndrome
Run by Peking Union Medical College Hospital · NCT06545721 · Data updated 2026-11-12
This program sees if a high-protein diet with exercise and behavioral support, and different amounts of weight loss or regain, improve androgen levels and insulin resistance in women with PCOS.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 425 (estimated) |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | August 13, 2024 |
| Main results expected | March 1, 2026 |
| Study ends | April 1, 2026 |
| Registry record updated | December 3, 2025 |
| Trial ID | NCT06545721 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–45 with PCOS by Rotterdam criteria who are willing to follow dietary, exercise, and behavioral programs and who fall into the study BMI ranges (normal 18.5–<24 kg/m2 or BMI ≥24 kg/m2) are ideal candidates.
✕Probably not a fit
Women who are pregnant, breastfeeding, planning pregnancy within six months, currently using prescription weight‑loss medications, with prior bariatric surgery, or with severe cardiovascular, cerebrovascular, or liver disease are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective cohort enrolling about 425 women with PCOS split into a normal-weight group and an overweight/obese group. Overweight/obese participants receive an intensive high-protein diet plus exercise and behavioral interventions for weight loss, while normal-weight participants receive energy-control and behavior support to prevent weight gain. Participants are followed at 3 and 6 months and categorized by percent weight change (<2%, 2–5%, 5–10%, ≥10%) to compare changes in insulin resistance, androgen levels, and inflammatory markers. The study also includes genetic/transcriptome analyses to explore molecular mechanisms linking weight change and weight cycling to PCOS manifestations.
Why it matters
Potential benefit: If successful, the results could clarify how much weight loss is needed to improve hormones and insulin resistance in PCOS and help set personalized weight‑loss targets.
How similar studies have gone: Previous research shows that modest weight loss often improves metabolic and reproductive outcomes in PCOS, but the specific effects of different weight‑loss thresholds and of weight cycling, especially at the transcriptome level, are less well characterized.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women aged 18-45 years in the reproductive period; 2. Women who have previously met the Rotterdam diagnostic criteria (at least 2 of the following 3 criteria have been confirmed, and have been diagnosed with PCOS): 1) Oligomenorrhea and/or anovulation; 2) clinical and/or biochemical evidence of hyperandrogenism; 3) ultrasound showing the presence of unilateral or bilateral polycystic ovaries; 3. Inclusion of 50 women in the normal weight group: 18.5 kg/m² ≤ BMI \< 24 kg/m²; Inclusion of 400 women in the overweight/obese group: BMI ≥ 24 kg/m²; 4. Voluntarily participate in the intervention and sign an informed consent form. Exclusion Criteria: 1. Currently pregnant or lactating, or have had a recent (within 6 months) plan for pregnancy; 2. Currently using known prescription weight loss medications (such as GLP-1RA, orlistat, topiramate, etc.); 3. History of weight loss surgery; 4. History of severe cardiovascular or cerebrovascular diseases; severe liver or kidney dysfunction (ALT \> 3 times the upper limit of normal, or creatinine \> 1.5 times the upper limit of normal); chronic or active gastrointestinal inflammatory diseases; severe systemic diseases; active malignant tumors; 5. Secondary obesity: including hypothalamic or pituitary obesity, obesity secondary to glucocorticoid use, hypogonadism-induced obesity, etc.; 6. Known history of serious endocrine system diseases; 7. Poor compliance with planned dietary interventions (psychiatric disorders such as binge eating disorder, anorexia nervosa, severe anxiety/depression); 8. Unable to follow up on time or deemed non-cooperative by the investigator.
Where it's running
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Wei Chen, PhD — Peking Union Medical College Hospital
- Study coordinator: Wei Chen, PhD
- Email: txchenwei@sina.com
- Phone: 13911006820
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Precision acupuncture and lifestyle for PCOS
This trial tests whether a precision acupuncture approach combined with a personalized lifestyle plan helps improve insulin resistance in people with PCOS compared with conventional acupuncture and standard lifestyle changes.
-
Orlistat for metabolic and hormonal features in women with PCOS
This trial tests whether adding orlistat to lifestyle advice helps improve metabolic and hormonal aspects in women with PCOS compared to lifestyle advice alone.
-
Physical activity program for women with PCOS and fatty pancreas plus subclinical hypothyroidism
A program of exercise is being tested to see if it helps women with PCOS who also have fatty pancreas and subclinical hypothyroidism, compared to usual care.
-
Glucose monitoring in women with polycystic ovary syndrome
This project will use continuous glucose monitors to see if daily glucose patterns differ among adult women with different PCOS phenotypes.
-
Adding regular exercise to a low‑calorie diet and metformin for women with PCOS and asthma
This study will test whether adding regular treadmill walking to a low‑calorie diet and daily metformin helps women who have both PCOS and asthma.
-
Identifying insulin-resistant PCOS with LMNA-related lipodystrophy in young women
We’re testing whether women with a genetic insulin resistance and lipodystrophy differ from women with PCOS by age and BMI matching.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.